Hear directly from Castle Biosciences, the company behind the Gene Expression Profile (GEP) test developed in collaboration with Bill Harbour.
This talk was delivered at the 2017 Eye Am Not Alone (EANA) patient and caregivers conference at Stanford University. More information is available at ocularmelanoma.....
Speakers:
Derek Maetzold
Kristin Oelschlager, RN
--
Castle Biosciences is a molecular diagnostics and prognostics company dedicated to helping patients and physicians make optimal decisions regarding treatment and follow-up care based on the tumor’s unique molecular signature. The Company currently offers prognostic tests for patients with rare cancers including uveal and cutaneous melanoma, esophageal, thymoma and brain cancers as well as malignant pleural mesothelioma. More information can be found at www.castlebiosciences.com.
Information on the uveal melanoma testing can be found at myuvealmelanoma.com.
Негізгі бет Overview of Melanoma Gene Expression Profile (GEP) Test by Castle Biosciences
Пікірлер